Product NDC: | 44206-251 |
Proprietary Name: | AlbuRx |
Non Proprietary Name: | ALBUMIN (HUMAN) |
Active Ingredient(s): | 12.5 g/50mL & nbsp; ALBUMIN (HUMAN) |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44206-251 |
Labeler Name: | CSL Behring AG |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA102366 |
Marketing Category: | BLA |
Start Marketing Date: | 20090106 |
Package NDC: | 44206-251-10 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (44206-251-10) > 100 mL in 1 VIAL, GLASS (44206-251-91) |
NDC Code | 44206-251-10 |
Proprietary Name | AlbuRx |
Package Description | 1 VIAL, GLASS in 1 CARTON (44206-251-10) > 100 mL in 1 VIAL, GLASS (44206-251-91) |
Product NDC | 44206-251 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | ALBUMIN (HUMAN) |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090106 |
Marketing Category Name | BLA |
Labeler Name | CSL Behring AG |
Substance Name | ALBUMIN (HUMAN) |
Strength Number | 12.5 |
Strength Unit | g/50mL |
Pharmaceutical Classes | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |